News

According to Verizon Business, BlueJeans Telehealth is way for providers and patients to conduct data-driven virtual care conversations.

During the trial, a patient gained vision, which lasted more than a year, after a single injection of an experimental RNA therapy into the eye.

The American Academy of Ophthalmology’s Truhlsen-Marmor Museum of the Eye is offering a free 2-part virtual series that will provide attendees an idea what is going on inside of their very own eyes and gut.

TCT can offer survival benefits for patients with a wide range of cancer diagnoses.

Study highlights role of demographic and socioeconomic characteristics in treatment.

Drinking alcohol on a regular basis may decrease patients’ chances of developing cataracts that require surgery, new research shows.

Check out the latest cartoon!

Ophthalmologist offers pearls for management, treatment of myriad issues.

FLIO provides earlier diagnostic capabilities than other imaging modalities.

Doug Mastel, who founded Mastel Precision Surgical Instruments Inc., passed away on March 20. He was 67.

Option demonstrates stable to improved visual acuity and retinal thickness.

Ophthalmologists refine procedures, offer better outcomes for patients.

Pearls for ophthalmologists guides for handling damage during open globe repair.

Rapid fluid identification may result in better visual outcomes.

A decision to stop the trial is based on results of a pre-planned interim sample size analysis conducted by an independent committee.

NCP should be considered for patients with discomfort, irritation, dryness, grittiness.

Physicians should consider basing decisions on findings from comprehensive consultation and examination.

Clinical-stage pharma company announces next step in investigation of BRIMOCHOL to treat presbyopia.

Product offers improvement in objective dry eye disease measures, providing relief.

ProQR Therapeutics has unveiled the results from its Phase 1/2 Stellar trial examining QR-421a n patients with Usher syndrome and non-syndromic retinitis pigmentosa.

A clinical trial of NCX 470 will evaluate the drug for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension.

A word from Chief Medical Editor Peter J. McDonnell, MD.

SemaThera Inc. has announced a research collaboration and licensing agreement with Roche to develop a new class of biologicals for the treatment of diabetic retinopathy and other ischemic retinal diseases.

Ophthalmologists can opt to use vital stains for cultures and corneal scrapings.

Studies highlight need for specialists and training programs focusing on the disease

A group of French researchers is hoping its work to develop an artificial retina will help blind people see again.

Phase 2 trial of 0.3% minocycline microparticle suspension shows promise in dry eye diseases associated with Inflamed meibomian gland dysfunction